Diabetes 54:3282-3287, 2005
© 2005 by the American Diabetes Association, Inc.
Reduced Nitric Oxide Concentration in the Renal Cortex of Streptozotocin-Induced Diabetic RatsEffects on Renal Oxygenation and Microcirculation
Fredrik Palm1,
Donald G. Buerk2,
Per-Ola Carlsson1,3,
Peter Hansell1, and
Per Liss4
1 Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
2 Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
3 Department of Medical Sciences, Uppsala University, Uppsala, Sweden
4 Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
Nitric oxide (NO) regulates vascular tone and mitochondrial respiration. We investigated the hypothesis that there is reduced NO concentration in the renal cortex of diabetic rats that mediates reduced renal cortical blood perfusion and oxygen tension (PO2). Streptozotocin-induced diabetic and control rats were injected with L-arginine followed by N -nitro-L-arginine-metyl-ester (L-NAME). NO and PO2 were measured using microsensors, and local blood flow was recorded by laser-Doppler flowmetry. Plasma arginine and asymmetric dimethylarginine (ADMA) were analyzed by high-performance liquid chromatography. L-Arginine increased cortical NO concentrations more in diabetic animals, whereas changes in blood flow were similar. Cortical PO2 was unaffected by L-arginine in both groups. L-NAME decreased NO in control animals by 87 ± 15 nmol/l compared with 45 ± 7 nmol/l in diabetic animals. L-NAME decreased blood perfusion more in diabetic animals, but it only affected PO2 in control animals. Plasma arginine was significantly lower in diabetic animals (79.7 ± 6.7 vs. 127.9 ± 3.9 mmol/l), whereas ADMA was unchanged. A larger increase in renal cortical NO concentration after L-arginine injection, a smaller decrease in NO after L-NAME, and reduced plasma arginine suggest substrate limitation for NO formation in the renal cortex of diabetic animals. This demonstrates a new mechanism for diabetes-induced alteration in renal oxygen metabolism and local blood flow regulation.
Address correspondence and reprint requests to Fredrik Palm, PhD, Department of Medical Cell Biology, Uppsala University, Biomedical Center, Box 571, SE-751 23 Uppsala, Sweden. E-mail: fredrik.palm{at}medcellbiol.uu.se
Abbreviations:
ADMA, asymmetric dimethylarginine; GFR, glomerular filtration rate; L-NAME, N -nitro-L-arginine-metyl-ester; NOS, NO synthase; ROS, reactive oxygen species; SDMA, symmetric dimethylarginine; STZ, streptozotocin

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. L. Onozato, A. Tojo, J. Leiper, T. Fujita, F. Palm, and C. S. Wilcox
Expression of NG,NG-Dimethylarginine Dimethylaminohydrolase and Protein Arginine N-Methyltransferase Isoforms in Diabetic Rat Kidney: Effects of Angiotensin II Receptor Blockers
Diabetes,
January 1, 2008;
57(1):
172 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shi, D. Patschan, T. Epstein, M. S. Goligorsky, and J. Winaver
Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury
Am J Physiol Renal Physiol,
November 1, 2007;
293(5):
F1512 - F1517.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|